Shingles Vaccine Cuts Post-Herpetic Neuralgia Risk 90%, Eases Pain Even After Infection
Updated
Updated · Detroit News · Aug 18
Shingles Vaccine Cuts Post-Herpetic Neuralgia Risk 90%, Eases Pain Even After Infection
3 articles · Updated · Detroit News · Aug 18
Summary
Dr. Roach said people who get shingles despite vaccination often have milder illness, with the shot reducing acute pain severity even when it does not fully prevent infection.
The vaccine also cuts pain-medication use by 40% and shortens pain-med duration by 50%, while lowering the risk of post-herpetic neuralgia—persistent pain after shingles—by about 90%.
Valacyclovir and other antivirals can further reduce pain and inflammation, but work best when started within 24 hours of the rash and no later than 72 hours.
Eye involvement needs urgent ophthalmology care because shingles can be diagnosed quickly but also mistaken for other infections, and some eye complications may require intravenous antivirals.
Dr. Roach recommended shingles vaccination for all adults over 50 and for immunocompromised adults of any age unless a specific contraindication exists.